Recent changes

Jump to navigation Jump to search

Track the most recent changes to the wiki on this page.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 07:01, 9 June 2023
   
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

9 June 2023

 m   01:50  Bortezomib (Velcade) diffhist +187 Jwarner talk contribs
 m   01:49  Lenvatinib (Lenvima) diffhist +283 Jwarner talk contribs →‎History of changes in PMDA indication
 m   01:48  Trametinib (Mekinist) diffhist +151 Jwarner talk contribs →‎History of changes in PMDA indication
 m   01:47  Dabrafenib (Tafinlar) diffhist +178 Jwarner talk contribs →‎History of changes in PMDA indication
 m   01:43  Ketoconazole (Nizoral) diffhist +3 Jwarner talk contribs
 m   01:43  Galeterone (TOK-001) diffhist -39 Jwarner talk contribs
 m   01:42  Orteronel (TAK-700) diffhist +20 Jwarner talk contribs
N    01:42  Category:CYP17 inhibitors diffhist +41 Jwarner talk contribs Created page with "Category:Steroid synthesis inhibitors"
 m   01:42  Abiraterone (Zytiga) diffhist +178 Jwarner talk contribs
 m   01:39  Olaparib (Lynparza) diffhist +209 Jwarner talk contribs
 m   01:37  Inotuzumab ozogamicin (Besponsa)‎‎ 2 changes history +236 [Jwarner‎ (2×)]
 m   
01:37 (cur | prev) +2 Jwarner talk contribs →‎History of changes in PMDA indication
 m   
01:37 (cur | prev) +234 Jwarner talk contribs
 m   01:36  Atezolizumab (Tecentriq) diffhist +116 Jwarner talk contribs
 m   01:34  Pembrolizumab (Keytruda)‎‎ 3 changes history +367 [Jwarner‎ (3×)]
 m   
01:34 (cur | prev) +179 Jwarner talk contribs →‎History of changes in PMDA indication
 m   
01:34 (cur | prev) +187 Jwarner talk contribs →‎History of changes in PMDA indication
 m   
01:33 (cur | prev) +1 Jwarner talk contribs →‎=Non-small cell lung cancer
 m   01:32  Fulvestrant (Faslodex) diffhist +131 Jwarner talk contribs
 m   01:30  Avelumab (Bavencio) diffhist +121 Jwarner talk contribs
 m   01:30  Daratumumab (Darzalex) diffhist +128 Jwarner talk contribs
 m   01:29  Palbociclib (Ibrance) diffhist +127 Jwarner talk contribs
 m   01:28  Nivolumab (Opdivo) diffhist +163 Jwarner talk contribs →‎Gastric cancer
 m   01:27  Ceritinib (Zykadia) diffhist +182 Jwarner talk contribs
 m   01:26  Lanreotide (Somatuline) diffhist +219 Jwarner talk contribs
 m   01:25  Romidepsin (Istodax) diffhist +178 Jwarner talk contribs
 m   01:25  Pralatrexate (Folotyn)‎‎ 2 changes history +166 [Jwarner‎ (2×)]
 m   
01:25 (cur | prev) +10 Jwarner talk contribs →‎Also known as
 m   
01:24 (cur | prev) +156 Jwarner talk contribs
N    01:24  Category:PMDA approved in 2017 diffhist +32 Jwarner talk contribs Created page with "Category:PMDA approved drugs"
 m   01:23  Regorafenib (Stivarga) diffhist +191 Jwarner talk contribs
 m   01:22  Crizotinib (Xalkori) diffhist +190 Jwarner talk contribs
 m   01:21  Rituximab (Rituxan) diffhist +150 Jwarner talk contribs →‎History of changes in PMDA indication
 m   01:19  Olanzapine (Zyprexa) diffhist +257 Jwarner talk contribs
 m   01:18  Cyclosporine diffhist +154 Jwarner talk contribs
 m   01:17  Eltrombopag (Promacta) diffhist +175 Jwarner talk contribs

8 June 2023

 m   20:54  Trastuzumab deruxtecan (Enhertu) diffhist +10 Jwarner talk contribs →‎Breast cancer
 m   20:52  Bendamustine diffhist +91 Jwarner talk contribs →‎History of changes in PMDA indication
 m   20:51  Cytarabine (Ara-C) diffhist +136 Jwarner talk contribs
 m   20:50  Cyclophosphamide (Cytoxan) diffhist +95 Jwarner talk contribs →‎History of changes in PMDA indication
 m   20:50  Fludarabine (Fludara) diffhist +96 Jwarner talk contribs →‎History of changes in PMDA indication
 m   20:49  Etoposide (Vepesid) diffhist +136 Jwarner talk contribs
 m   20:48  Rituximab (Rituxan) diffhist +126 Jwarner talk contribs →‎History of changes in PMDA indication
 m   20:47  Thiotepa (Thioplex) diffhist +193 Jwarner talk contribs
 m   20:46  Apalutamide (Erleada) diffhist +140 Jwarner talk contribs
 m   20:45  Temozolomide (Temodar) diffhist +176 Jwarner talk contribs
 m   20:44  Dacomitinib (Vizimpro) diffhist +204 Jwarner talk contribs
 m   20:44  Binimetinib (Mektovi) diffhist +133 Jwarner talk contribs
 m   20:43  Encorafenib (Braftovi) diffhist +133 Jwarner talk contribs
 m   20:42  Pembrolizumab (Keytruda) diffhist +536 Jwarner talk contribs
 m   20:40  Pertuzumab (Perjeta) diffhist +82 Jwarner talk contribs →‎History of changes in PMDA indication
 m   20:39  Fluorouracil (5-FU) diffhist +169 Jwarner talk contribs
 m   20:38  Levoleucovorin (Fusilev) diffhist +221 Jwarner talk contribs